Table 4.
Milan Biometric Surgical Score for Intracranial Meningiomas (MBSS-Men Score; Part A) | ||||||||
ITEM | MEASURE | SCORE VALUE | ||||||
ASA Score | 1–2 | 0 | ||||||
>2 | 3 | |||||||
Frailty Index | <0.10 | 0 | Multivariate regression analysis | Odd Ratio (OD) | Standard Error (S.E.) | p Value | 95% C.I. | |
0.10–0.20 | 2 | |||||||
>0.20 | 3 | Post-operative prognostic Score | MBSS (Part A) | 2.611 | 0.293 | 0.001 | 1.469–4.640 | |
Skull base location | Yes | 1 | Constant | 0 | 3.056 | 0 | ||
No | 0 | |||||||
Infratentorial location | Yes | 3 | AUR-ROC analysis | Area (AUC) | Std. Error (S.E.) | p Value | 95% C.I. | |
No | 0 | |||||||
Diameter > 2.5 cm | >25 mm | 3 | Overall population | 0.956 | 0.034 | 0 | 0.890–1.022 | |
<25 mm | 0 | Age 18–65 years | 0.878 | 0.042 | 0 | 0.794–0.961 | ||
Tumor-Brain cleft on T2WI | Absent | 2 | Age > 65 years | 0.981 | 0.017 | 0 | 0.948–1.013 | |
Present | 0 | Age > 70 years | 0.973 | 0.024 | 0 | 0.926–1.020 | ||
RANGE | 0–15 | Age > 80 years | 0.911 | 0.074 | 0 | 0.765–1.057 | ||
Milan Biometric Surgical Score for intracranial meningiomas (MBSS-Men Score; Part B) | ||||||||
Frailty Index | <0.10 | 0 | ||||||
0.10–0.20 | 1 | |||||||
>0.20 | 3 | |||||||
Infratentorial location | Yes | 2 | ||||||
No | 0 | Multivariate regression analysis | Odd Ratio (OD) | Standard Error (S.E.) | p Value | 95% C.I. | ||
Diameter > 2.5 cm | >25 mm | 1 | ||||||
<25 mm | 0 | Follow-up prognostic Score | MBSS (Part B) | 2.961 | 0.203 | 0 | 1.988–4.411 | |
Severe peritumoral edema | Yes | 1 | Constant | 0.004 | 0.876 | 0 | ||
No | 0 | |||||||
Sinus Invasion | Yes | 1 | AUR-ROC analysis | Area (AUC) | Std. Error (S.E.) | p Value | 95% C.I. | |
No | 0 | |||||||
DWI hyperintensity | Present | 1 | Overall population | 0.877 | 0.033 | 0 | 0.811–0.942 | |
Absent | 0 | Age 18–65 years | 0.901 | 0.04 | 0 | 0.823–0.978 | ||
Tumor-Brain cleft in T2WI | Absent | 1 | Age > 65 years | 0.854 | 0.054 | 0 | 0.749–0.959 | |
Present | 0 | Age > 70 years | 0.85 | 0.055 | 0 | 0.741–0.959 | ||
RANGE | 0–10 | Age > 80 years | 0.861 | 0.088 | 0 | 0.689–1.033 |
(Left) The parameters independently associated with the outcomes investigated were selected and filled into a newly designed prognostic score. The Milan Biometric Surgical Score (MBSS) was split in two subparts: Part A comprehended all of the significant predictors of early post-operative functional outcome, while Part B comprehended those predictors affecting long-term functional outcome and quality of life. A chart for MBSS was designed and each parameter was given a value according to its odds ratio on a multivariable regression analysis. MBSS-Part A had a range from 0 to 15. MBSS-Part B had a range from 0 to 10. (Right) The current table reports the classification analysis of MBSS Part A and Part B in predicting early post-operative functional deterioration and long-term unfavourable outcome at follow-up, respectively. Each sub-score was tested first on the overall population and then on the age-specific subgroups.